Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer

被引:64
|
作者
Kushchayeva, Yevgeniya [1 ]
Duh, Quan-Yang [1 ]
Kebebew, Electron [1 ]
D'Avanzo, Alessandra [1 ]
Clark, Orlo H. [1 ]
机构
[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA
来源
AMERICAN JOURNAL OF SURGERY | 2008年 / 195卷 / 04期
关键词
Hurthle cell; follicular cancer; risk factors;
D O I
10.1016/j.amjsurg.2007.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hurthle cell cancer (HCC) is considered by some to be a variant of follicular cancer (FC), but many think it is a distinct histologic tumor with a more aggressive behavior. Methods: The influence of age at diagnosis, tumor stage, gender, and extent of operation on disease-free interval and cause-specific mortality at 5 and 10 years after initial thyroidectomy was analyzed. Results: The 10-year disease-free interval was 75% for FC and 40.5% for HCC (P = .08). The 10-year cause-specific mortality was 20% for FC patients and 51% for HCC (P = .2). The risk factors for HCC progression and survival were extrathyroidal invasion, presence of metastases at diagnosis, male gender, and extent of thyroidectomy, whereas for FC, the only significant risk factors were extrathyroidal invasion and presence of metastases at diagnosis. Conclusion: Patients with HCC have more aggressive tumors than patients with FC. Our data suggest that FC and HCC should be classified as distinct tumors. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 50 条
  • [1] Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hurthle cell carcinoma
    Ernaga Lorea, Ander
    Migueliz Bermejo, Iranzu
    Anda Apinaniz, Emma
    Pineda Arribas, Javier
    Toni Garcia, Marta
    Martinez de Esteban, Juan Pablo
    Insausti Serrano, Ana Maria
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (03): : 136 - 142
  • [2] Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
    Grani, Giorgio
    Lamartina, Livia
    Durante, Cosimo
    Filetti, Sebastiano
    Cooper, David S.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (06): : 500 - 514
  • [3] Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients
    Schlumberger, M.
    Hitzel, A.
    Toubert, M. E.
    Corone, C.
    Troalen, F.
    Schlageter, M. H.
    Claustrat, F.
    Koscielny, S.
    Taieb, D.
    Toubeau, M.
    Bonichon, F.
    Borson-Chazot, F.
    Leenhardt, L.
    Schvartz, C.
    Dejax, C.
    Brenot-Rossi, I.
    Torlontano, M.
    Tenenbaum, F.
    Bardet, S.
    Bussiere, F.
    Girard, J. J.
    Morel, O.
    Schneegans, O.
    Schlienger, J. L.
    Prost, A.
    So, D.
    Archambeaud, F.
    Ricard, M.
    Benhamou, E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07): : 2487 - 2495
  • [4] Clinical characteristics and follow-up of intracranial metastases from thyroid cancer
    Heui Seung Lee
    Heon Yoo
    Seung Hoon Lee
    Ho Shin Gwak
    Sang Hoon Shin
    Acta Neurochirurgica, 2015, 157 : 2185 - 2194
  • [5] Clinical characteristics and follow-up of intracranial metastases from thyroid cancer
    Lee, Heui Seung
    Yoo, Heon
    Lee, Seung Hoon
    Gwak, Ho Shin
    Shin, Sang Hoon
    ACTA NEUROCHIRURGICA, 2015, 157 (12) : 2185 - 2194
  • [6] Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients
    Alexopoulou, O
    Beguin, C
    De Nayer, P
    Maiter, D
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (01) : 1 - 8
  • [7] Clinical impact of follicular oncocytic (Hurthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
    Wenter, Vera
    Albert, Nathalie L.
    Unterrainer, Marcus
    Ahmaddy, Freba
    Ilhan, Harun
    Jellinek, Annamirl
    Knoesel, Thomas
    Bartenstein, Peter
    Spitzweg, Christine
    Lehner, Sebastian
    Todica, Andrei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) : 449 - 460
  • [8] Comparison of Calcium and Pentagastrin Tests for the Diagnosis and Follow-Up of Medullary Thyroid Cancer
    Colombo, Carla
    Verga, Uberta
    Mian, Caterina
    Ferrero, Stefano
    Perrino, Michela
    Vicentini, Leonardo
    Dazzi, Davide
    Opocher, Giuseppe
    Pelizzo, Maria Rosa
    Beck-Peccoz, Paolo
    Fugazzola, Laura
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : 905 - 913
  • [9] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Pacini, F.
    Castagna, M. G.
    Brilli, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 110 - 119
  • [10] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Filetti, S.
    Durante, C.
    Hartl, D.
    Leboulleux, S.
    Locati, L. D.
    Newbold, K.
    Papotti, M. G.
    Berruti, A.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1856 - 1883